Aged
Aged, 80 and over
Androgen Antagonists/*therapeutic use
Antineoplastic Agents/*therapeutic use
Disease Progression
Double-Blind Method
Factor Analysis, Statistical
Humans
Imidazoles/*therapeutic use
*Imidazolidines
Male
Middle Aged
*Orchiectomy
Prognosis
Proportional Hazards Models
Prostatic Neoplasms/*drug therapy/pathology/*surgery
Survival Analysis
Treatment Outcome
